Fukumoto Nobu, Miyamoto Kyohei, Nakashima Tsuyoshi, Kato Seiya
Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, JPN.
Cureus. 2023 May 17;15(5):e39138. doi: 10.7759/cureus.39138. eCollection 2023 May.
Few cases of acute respiratory distress syndrome (ARDS) in severe fever with thrombocytopenia syndrome (SFTS) have been treated with venovenous extracorporeal membrane oxygenation (VV-ECMO), and its role remains unclear. A 73-year-old Japanese woman presented with multiple organ failure (MOF) due to SFTS, including liver, neural, hematologic, renal, and ARDS. VV-ECMO for refractory hypoxemia under lung-protective ventilation with prone positioning led to gradual respiratory improvement, and she was successfully weaned on the 19th day of hospitalization. However, she died from persistent MOF on the 60th day of hospitalization. VV-ECMO contributed to recovery from ARDS but not from the ultimate cause of death, i.e., MOF. SFTS could have variable MOFs with different disease trajectories, which influence the decision for VV-ECMO.
严重发热伴血小板减少综合征(SFTS)合并急性呼吸窘迫综合征(ARDS)的病例很少采用静脉-静脉体外膜肺氧合(VV-ECMO)治疗,其作用仍不明确。一名73岁的日本女性因SFTS出现多器官功能衰竭(MOF),包括肝脏、神经、血液、肾脏和ARDS。在俯卧位肺保护性通气下,采用VV-ECMO治疗难治性低氧血症,患者呼吸逐渐改善,并于住院第19天成功脱机。然而,她在住院第60天死于持续性MOF。VV-ECMO有助于ARDS的恢复,但不能消除最终死因,即MOF。SFTS可能有不同的疾病轨迹和多种MOF,这会影响VV-ECMO的决策。